EGFP mRNA (N1-Me-pseudo U)
| Catalog No. | ON-278 |
| Purity | N/A |
| Source | N/A |
EGFP mRNA (N1-Me-pseudo U)
EGFP mRNA (N1-Me-pseudo U) - M (Molecular Biology) / 1mg / centrifuge tube is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Details
Details
EGFP mRNA is a chemically modified messenger RNA molecule capable of expressing enhanced green fluorescent protein (EGFP), and is mainly used for gene expression detection, transfection efficiency evaluation, and protein localization tracking in biomedical research. Through optimization of co-transcription with cap addition, it has high translation efficiency and stability, and is suitable for experiments in cells. This product effectively reduces the immunogenicity of mRNA expression in mammalian cless and enhances the stablility of mRNA by N1-Me-pseudo U modifications.
Concentration: 1.0 mg/mL
Buffer: 1 mM Sodium Citrate pH 6.4
Modifications: N1-Methyl-Pseudo-U
Endotoxin: < 1 EU/mg
Bioanalyzer of Final Product: Passes Capillary Electrophoresis
Specifications
Specifications
-
Catalog No.ON-278
-
SourceN/A
-
PurityN/A
Documentation
Documentation
EGFP mRNA is a chemically modified messenger RNA molecule capable of expressing enhanced green fluorescent protein (EGFP), and is mainly used for gene expression detection, transfection efficiency evaluation, and protein localization tracking in biomedical research. Through optimization of co-transcription with cap addition, it has high translation efficiency and stability, and is suitable for experiments in cells. This product effectively reduces the immunogenicity of mRNA expression in mammalian cless and enhances the stablility of mRNA by N1-Me-pseudo U modifications.
Concentration: 1.0 mg/mL
Buffer: 1 mM Sodium Citrate pH 6.4
Modifications: N1-Methyl-Pseudo-U
Endotoxin: < 1 EU/mg
Bioanalyzer of Final Product: Passes Capillary Electrophoresis
-
Catalog No.ON-278
-
SourceN/A
-
PurityN/A
Why choose Hongene?
Trusted Partner in Nucleic Acid
Enjoy enterprise‑grade quality even with small batch orders.
Integrated Supply & Commercial Scale
With nearly 30 years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates a 1.67-million-square-foot oligonucleotide manufacturing facility featuring advanced equipment, including multiple OligoPilot™ and OligoProcess™ synthesizers ranging from 10 to 1,800 mmol. Its 48 flexible production lines enable seamless, one-stop scale-up of API production from gram-level quantities to metric tons, achieving purity of ≥98% while supporting compliance with NMPA, FDA, and EMA regulatory requirements.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
